Samuel J. Reich - 05 Feb 2026 Form 4 Insider Report for SAB Biotherapeutics, Inc. (SABS)

Role: CEO, Director
Signature: /s/ Samuel J. Reich
Issuer symbol: SABS
Transactions as of: 05 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 05 Feb 2026, 16:50:05 UTC
Previous filing: 28 Aug 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Reich Samuel J	CEO, Director	777 W 41ST STREET, SUITE 401, MIAMI BEACH	/s/ Samuel J. Reich	05 Feb 2026	0001394645

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SABS	Stock option (right to buy)	Award	$0	+4,800,000		$0.000000	4,800,000	03 Feb 2026	Common Stock	4,800,000	$4.45	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents options to purchase shares of the Issuer's common stock par value $0.0001 per share, pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended.
F2	The shares underlying the option vest over a four-year period, vesting 1/4 on the one-year anniversary of the date of grant, and the remaining 3/4 vesting pro rata on a monthly basis in 36 equal installments thereafter.